# Cochlear Limited (CHEOY)

> Healthcare · AU · Reports in AUD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CHEOY/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 1.18B | $ -14.40M | $ 208.32M | $ 212.71M | $ 1.74B |
| 2025 | $ 2.34B | $ 342.34M | $ 199.20M | $ 427.38M | $ 1.94B |
| 2024 | $ 2.36B | $ 379.40M | $ 281.30M | $ 246.60M | $ 1.87B |
| 2023 | $ 2.31B | $ 371.80M | $ 354.93M | $ 206.70M | $ 1.78B |
| 2022 | $ 1.95B | $ 296.84M | $ 293.89M | $ 250.40M | $ 1.72B |
| 2021 | $ 1.87B | $ 309.80M | $ 278.54M | $ 266.10M | $ 1.73B |
| 2020 | $ 1.59B | $ -192.83M | $ -364.78M | $ 333.10M | $ 1.64B |
| 2019 | $ 1.86B | $ 377.09M | $ 158.09M | $ 422.40M | $ 806.00M |
| 2018 | $ 1.77B | $ 329.38M | $ 360.37M | $ 165.00M | $ 653.50M |
| 2017 | $ 1.65B | $ 283.95M | $ 256.83M | $ 244.00M | $ 574.80M |
| 2016 | $ 1.54B | $ 268.25M | $ 238.54M | $ 172.94M | $ 487.69M |
| 2015 | $ 1.38B | $ 221.98M | $ 188.05M | $ 213.11M | $ 415.35M |
| 2014 | $ 1.16B | $ 192.28M | $ 195.87M | $ 230.48M | $ 321.45M |
| 2013 | $ 1.01B | $ 104.35M | $ 73.00M | $ 226.32M | $ 322.42M |
| 2012 | $ 551.67M | $ 109.38M | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.12 |
| Liabilities / Eq | 0.50 |
| Current Ratio | 2.15 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.81 |
| Gross Debt / FCF | 0.99 |

## Other views

- [Metrics](https://sponda.capital/en/CHEOY.md)
- [Charts](https://sponda.capital/en/CHEOY/charts.md)
- [Compare](https://sponda.capital/en/CHEOY/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.